Species-Specific Unbound Fraction Differences in Highly Bound PFAS: A Comparative Study across Human, Rat, and Mouse Plasma and Albumin
- PMID: 38668476
- PMCID: PMC11054487
- DOI: 10.3390/toxics12040253
Species-Specific Unbound Fraction Differences in Highly Bound PFAS: A Comparative Study across Human, Rat, and Mouse Plasma and Albumin
Abstract
Per- and polyfluoroalkyl substances (PFAS) are a diverse group of fluorinated compounds which have yet to undergo comprehensive investigation regarding potential adverse health effects and bioaccumulative properties. With long half-lives and accumulative properties, PFAS have been linked to several toxic effects in both non-clinical species such as rat and mouse as well as human. Although biological impacts and specific protein binding of PFAS have been examined, there is no study focusing on the species-specific fraction unbound (fu) in plasma and related toxicokinetics. Herein, a presaturation equilibrium dialysis method was used to measure and validate the binding of 14 individual PFAS with carbon chains containing 4 to 12 perfluorinated carbon atoms and several functional head-groups to albumin and plasma of mouse (C57BL/6 and CD-1), rat, and human. Equivalence testing between each species-matrix combination showed positive correlation between rat and human when comparing fu in plasma and binding to albumin. Similar trends in binding were also observed for mouse plasma and albumin. Relatively high Spearman correlations for all combinations indicate high concordance of PFAS binding regardless of matrix. Physiochemical properties of PFAS such as molecular weight, chain length, and lipophilicity were found to have important roles in plasma protein binding of PFAS.
Keywords: PFAS; equilibrium dialysis; protein binding; toxicology.
Conflict of interest statement
Woodrow Burchett and Sam Zhang were employed by the company Pfizer Worldwide Research & Development, Pfizer Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment.Chem Res Toxicol. 2023 Jun 19;36(6):870-881. doi: 10.1021/acs.chemrestox.3c00003. Epub 2023 May 15. Chem Res Toxicol. 2023. PMID: 37184865 Free PMC article.
-
Quantitative Cross-Species Comparison of Serum Albumin Binding of Per- and Polyfluoroalkyl Substances from Five Structural Classes.bioRxiv [Preprint]. 2023 Nov 14:2023.11.10.566613. doi: 10.1101/2023.11.10.566613. bioRxiv. 2023. Update in: Toxicol Sci. 2024 Apr 29;199(1):132-149. doi: 10.1093/toxsci/kfae028 PMID: 38014292 Free PMC article. Updated. Preprint.
-
Quantitative cross-species comparison of serum albumin binding of per- and polyfluoroalkyl substances from five structural classes.Toxicol Sci. 2024 Apr 29;199(1):132-149. doi: 10.1093/toxsci/kfae028. Toxicol Sci. 2024. PMID: 38518100 Free PMC article.
-
A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics.Environ Health Perspect. 2023 Jul;131(7):76002. doi: 10.1289/EHP11885. Epub 2023 Jul 7. Environ Health Perspect. 2023. PMID: 37418334 Free PMC article. Review.
-
Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.Regul Toxicol Pharmacol. 2019 Aug;106:239-250. doi: 10.1016/j.yrtph.2019.05.008. Epub 2019 May 9. Regul Toxicol Pharmacol. 2019. PMID: 31078680 Review.
References
-
- Martinez B., Da Silva B.F., Aristizabal-Henao J.J., Denslow N.D., Osborne T.Z., Morrison E.S., Bianchi T.S., Bowden J.A. Increased levels of perfluorooctanesulfonic acid (PFOS) during Hurricane Dorian on the east coast of Florida. Environ. Res. 2022;208:112635. doi: 10.1016/j.envres.2021.112635. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources